RecruitingNCT07046494

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolarity type I

This recruiting study focuses on bipolarity and currently lists sites or participation links in United States.

BipolarityOtherFrom 18 Years to 65 Years

In plain English

Key information made simple

This study exists to explore whether the medication RAP-219 could improve care and understanding. Researchers are trying to understand how people respond to the medication RAP-219 in practice and what may need to be adjusted. For people living with Bipolarity, the gap between what sounds good on paper and what works in daily life is often important. If the findings are useful, they could help future care become more targeted, practical, and easier to trust. Taking part helps build the evidence that can improve understanding and care for others over time.

What to expect

Your next step

The official record suggests in-person participation through a hospital, with sites including Pillar Clinical Research - Little Rock in Little Rock, Woodland International Research Group in Little Rock, and Woodland Research Northwest in Rogers. Participation appears to involve a study treatment together with follow-up visits and routine safety or progress checks. The main fit is usually matching the main diagnosis and being able to follow the planned visits or tasks, while common reasons not to take part include active substance or alcohol problems that could affect the results and other factors that could make participation unsuitable. This is an early-stage study, which usually means a smaller group and a focus on learning how the approach behaves.

Official source

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.

Open source record

Interested?

Check my eligibility

Study reference: NCT07046494. Your email is the only field you need to provide here.

In practice

For you

Taking part may give access to a new approach being evaluated.

It requires regular visits and structured follow-up.

Requires travel, with in-person participation in United States.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com